Wednesday, 25 April 2018
Subscribe to our RSS Feed
Subscribe or Manage Preferences
Want to Receive News & Updates from AHDB?
Stay up to date on the latest information you need to devise benefit designs, make coverage decisions, and further value-based healthcare!

Sign up for our newsletter or print publications today by entering your contact information below and clicking "Subscribe".
First Name *
Last Name *
Email Address *
Email Address (Verify) *
We will request your mailing address on the next page.
 

Already a subscriber? Enter your email address below and click "Find" to look up and manage your current contact details and subscription preferences.
Email Address *
 
American Health & Drug Benefits
  • Home
  • Issues
    • 2018
      • April 2018 - Vol 11 No 2
      • February 2018 - Vol 11 No 1
    • 2017
      • December 2017 - Vol 10 No 9
      • November 2017 - Vol 10 No 8
      • October 2017 - Vol 10 No 7
      • September 2017 - Vol 10 No 6
      • July 2017 - Vol 10 No 5
      • June 2017 - Vol 10 No 4
      • May 2017 - Vol 10 No 3
      • April 2017 - Vol 10 No 2
      • February Vol 10 No 1
    • 2016
      • December 2016, Vol 9, No 9
      • November 2016 Vol 9, No 8
      • October 2016 Vol 9, No 7
      • September 2016, Vol 9, No 6
      • July 2016, Vol 9, No 5
      • June 2016, Vol 9, No 4
      • May 2016, Vol 9, No 3
      • April 2016, Vol 9, No 2
      • February 2016, Vol 9, No 1
    • Issue Archive
    • Value-Based Care in Cardiometabolic Health
  • Special Issues
    • Supplements
    • Newsletters
    • 2018 Special Issues
      • March 2018 Vol 11, Ninth Annual Payers' Guide
    • 2017 Special Issues
      • August 2017, Vol 10, Special Issue: Payers’ Perspectives in Oncology: ASCO 2017 Highlights
      • March 2017, Vol 10, Eighth Annual Payers' Guide
      • February 2017 Vol 10, Special Issue: Payers’ Perspectives In Oncology: ASH 2016 Highlights
    • 2016 Special Issues
    • Special Issue Archive
  • For Authors
    • Call for Papers
      • Submit a Manuscript
    • Instructions for Authors
    • Join Peer Review
      • Peer Reviewer Application
    • Permissions
  • Media Library
    • Video Library
  • In the News
    • In the News
    • Drug Updates
    • Web Exclusives
    • Press Releases
    • Conference Correspondent
      • ASH 2017 - CLL
      • ACR 2017 - Rheumatoid Arthritis
      • ASCO 2017 - Chronic Lymphocytic Leukemia
      • ASCO 2017 - Acute Myeloid Leukemia
      • ASH 2016 - Multiple Myeloma
      • ASH 2016 - Chronic Lymphocytic Leukemia
  • About Us
    • About AHDB
      • About Engage HC
    • Contact Us
    • Editorial Policies
    • Peer-Review Process
    • Editorial Board
    • Editorial Process
    • Advertising Contacts
    • Advertising Policy
    • Reprints
    • Glossary

Ajay S. Behl, PhD

Director of US Oncology Economics and Outcomes Research
Janssen Scientific Affairs
Titusville, NJ
Authored Items
Medication Adherence, Treatment Patterns, and Dose Reduction in Patients with Metastatic Castration-Resistant Prostate Cancer Receiving Abiraterone Acetate or Enzalutamide
Gary M. Owens, MD, Ajay S. Behl, PhD, Lorie A. Ellis, PhD, Dominic Pilon, MA, Yongling Xiao, PhD
September 2017 Vol 10, No 6 in Clinical, Original Research
Assessment of Real-World Central Nervous System Events in Patients with Advanced Prostate Cancer Using Abiraterone Acetate, Bicalutamide, Enzalutamide, or Chemotherapy
Dominic Pilon, MA, Brian Caveney, MD, JD, MPH, Ajay S. Behl, PhD, Lorie A. Ellis, PhD, Marie-Noëlle Robitaille, MA, Patrick Lefebvre, MA, Nancy A. Dawson, MD
May 2017 Vol 10, No 3 in Clinical
Last modified: September 22, 2017
  •  Association for Value-Based Cancer Care
  • Value-Based Cancer Care
  • Value-Based Care in Rheumatology
  • Oncology Practice Management
  • Rheumatology Practice Management
  • Urology Practice Management
  • Inside Patient Care: Pharmacy & Clinic
  • Lynx CME
  • Home
  • About
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Advertising Policy
Copyright © 2018 Engage Healthcare Communications, LLC. All rights reserved.